.. Colon-transverse, 48 4) Colon gauche et sigmoïde, p.50

L. Peyrin-biroulet, BIRD : le fardeau des MICI Résultats préliminaires Juillet 2015 ? Observatoire National des MICI [Internet], 2016.

M. Fumery, L. Dauchet, C. Vignal, and C. Gower-rousseau, [Epidemiology, risk factors and factors associated with disabling course in inflammatory bowel disease]. Rev Prat, pp.1210-1215, 2014.

F. Wolters, M. Russel, J. Sijbrandij, T. Ambergen, S. Odes et al., Phenotype at diagnosis predicts recurrence rates in Crohn's disease, Gut, vol.55, issue.8, pp.1124-1154, 2006.
DOI : 10.1136/gut.2005.084061

L. Peyrin-biroulet, histoire-naturelle-de-la-maladie-de-crohn.pdf [Internet] Available from, 2011.
DOI : 10.1007/978-2-8178-0237-4_12

J. Hugot, V. Jinternet, ]. Fmc-hge, and . Post-'u, Physiopathologie de la maladie de Crohn : l'indispensable pour le clinicien Available from, 2015.

S. Ng, C. Bernstein, M. Vatn, P. Lakatos, E. Loftus et al., Geographical variability and environmental risk factors in inflammatory bowel disease, Gut, vol.62, issue.4, pp.630-679
DOI : 10.1136/gutjnl-2012-303661

URL : http://gut.bmj.com/cgi/content/short/62/4/630

J. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J. Cézard et al., Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.599-603, 2001.
DOI : 10.1038/35079107

L. Antoni, S. Nuding, J. Wehkamp, and E. Stange, Intestinal barrier in inflammatory bowel disease, World Journal of Gastroenterology, vol.20, issue.5, pp.1165-79
DOI : 10.3748/wjg.v20.i5.1165

L. Jostins, S. Ripke, R. Weersma, R. Duerr, D. Mcgovern et al., Host???microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, vol.286, issue.7422, pp.119-143, 2012.
DOI : 10.1038/nature11582

X. Morgan, T. Tickle, H. Sokol, D. Gevers, K. Devaney et al., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment, Genome Biology, vol.13, issue.9, p.79, 2012.
DOI : 10.1186/gb-2011-12-6-r60

URL : https://hal.archives-ouvertes.fr/hal-00736429

M. Fumery, Available from, Quel est le vrai risque de Dysplasie/cancer sur sténoses intestinales au cours des maladies inflammatoires chroniques intestinales ? [Internet]. [cited 2016 Oct 1]

M. Laukoetter, R. Mennigen, C. Hannig, N. Osada, E. Rijcken et al., Intestinal Cancer Risk in Crohn???s Disease: A Meta-Analysis, Journal of Gastrointestinal Surgery, vol.12, issue.4, pp.576-83, 2009.
DOI : 10.1007/s11605-010-1402-9

R. Fornaro, M. Caratto, E. Caratto, G. Caristo, F. Fornaro et al., Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program, Clinical Colorectal Cancer, vol.15, issue.3, 2016.
DOI : 10.1016/j.clcc.2016.02.002

D. Hurlstone, D. Sanders, A. Lobo, M. Mcalindon, and S. Cross, Indigo Carmine-Assisted High-Magnification Chromoscopic Colonoscopy for the Detection and Characterisation of Intraepithelial Neoplasia in Ulcerative Colitis: A Prospective Evaluation, Endoscopy, vol.37, issue.12, pp.1186-92, 2005.
DOI : 10.1055/s-2005-921032

A. Von-roon, G. Reese, J. Teare, V. Constantinides, A. Darzi et al., The risk of cancer in patients with Crohn's disease. Dis Colon Rectum, pp.839-55, 2007.

S. Friedman, P. Rubin, C. Bodian, N. Harpaz, and D. Present, Screening and Surveillance Colonoscopy in Chronic Crohn's Colitis: Results of a Surveillance Program Spanning 25 Years, Clinical Gastroenterology and Hepatology, vol.6, issue.9, pp.993-998, 2008.
DOI : 10.1016/j.cgh.2008.03.019

S. Itzkowitz and D. Present, Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.11, issue.3, pp.314-335, 2005.
DOI : 10.1097/01.MIB.0000160811.76729.d5

L. Vuitton, F. Gonzalez, and S. Koch, Endoscopic screening of dysplasia in inflammatory bowel disease, Acta Endoscopica, vol.45, issue.suppl1
DOI : 10.1007/s10190-013-0328-y

C. Mowat, A. Cole, A. Windsor, T. Ahmad, I. Arnott et al., Guidelines for the management of inflammatory bowel disease in adults, Gut, vol.60, issue.5, pp.571-607, 2011.
DOI : 10.1136/gut.2010.224154

B. Pariente, J. Cosnes, S. Danese, W. Sandborn, M. Lewin et al., Development of the Crohn??s disease digestive damage score, the L??mann score, Inflammatory Bowel Diseases, vol.17, issue.6, pp.1415-1437, 2011.
DOI : 10.1002/ibd.21506

M. Allez, M. Lemann, J. Bonnet, P. Cattan, R. Jian et al., Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy, The American Journal of Gastroenterology, vol.97, issue.4, pp.947-53, 2002.
DOI : 10.1016/S0002-9270(02)03970-9

F. Schnitzler, H. Fidder, M. Ferrante, M. Noman, I. Arijs et al., Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn??s disease, Inflammatory Bowel Diseases, vol.15, issue.9, pp.1295-301, 2009.
DOI : 10.1002/ibd.20927

F. Baert, L. Moortgat, G. Van-assche, P. Caenepeel, P. Vergauwe et al., Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease, Gastroenterology, vol.138, issue.2, pp.463-468, 2010.
DOI : 10.1053/j.gastro.2009.09.056

P. Rutgeerts, R. Diamond, M. Bala, A. Olson, G. Lichtenstein et al., Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease, Gastrointestinal Endoscopy, vol.63, issue.3, pp.433-442, 2006.
DOI : 10.1016/j.gie.2005.08.011

K. Frøslie, J. Jahnsen, B. Moum, M. Vatn, and . Ibsen-group, Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort, Gastroenterology, vol.133, issue.2, pp.412-434, 2007.
DOI : 10.1053/j.gastro.2007.05.051

C. Pagnini, F. Menasci, F. Desideri, V. Corleto, D. Fave et al., Endoscopic scores for inflammatory bowel disease in the era of " mucosal healing " : Old problem, new perspectives. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, pp.703-711, 2016.

J. Mary and R. Modigliani, Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)., Gut, vol.30, issue.7, pp.983-992, 1989.
DOI : 10.1136/gut.30.7.983

D. Bernardini and D. Laharie, Cicatrisation muqueuse endoscopique Available from, 2013.
DOI : 10.1007/s10190-013-0315-3

M. Daperno, D. Haens, G. Van-assche, G. Baert, F. Bulois et al., Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD, Gastrointestinal Endoscopy, vol.60, issue.4, pp.505-517, 2004.
DOI : 10.1016/S0016-5107(04)01878-4

P. Rutgeerts, K. Geboes, G. Vantrappen, J. Beyls, R. Kerremans et al., Predictability of the postoperative course of Crohn's disease, Gastroenterology, vol.99, issue.4, pp.956-63, 1990.
DOI : 10.1016/0016-5085(90)90613-6

G. Van-assche, A. Dignass, W. Reinisch, C. Van-der-woude, A. Sturm et al., The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations, Journal of Crohn's and Colitis, vol.4, issue.1, pp.63-101, 2010.
DOI : 10.1016/j.crohns.2009.09.009

J. Panes, Y. Bouhnik, W. Reinisch, J. Stoker, S. Taylor et al., Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines, Journal of Crohn's and Colitis, vol.7, issue.7, pp.556-85, 2013.
DOI : 10.1016/j.crohns.2013.02.020

M. Zappa and Y. Bouhnik, Apport de l'échographie et de l'entéro-IRM dans la maladie de Crohn (hors LAP) [Internet]

K. Horsthuis, S. Bipat, R. Bennink, and J. Stoker, Inflammatory Bowel Disease Diagnosed with US, MR, Scintigraphy, and CT: Meta-analysis of Prospective Studies, Radiology, vol.247, issue.1, pp.64-79, 2008.
DOI : 10.1148/radiol.2471070611

J. Rimola, S. Rodriguez, O. García-bosch, I. Ordás, E. Ayala et al., Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease, Gut, vol.58, issue.8, pp.1113-1133, 2009.
DOI : 10.1136/gut.2008.167957

M. Steward, S. Punwani, I. Proctor, Y. Adjei-gyamfi, F. Chatterjee et al., Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index, European Journal of Radiology, vol.81, issue.9, pp.2080-2088, 2012.
DOI : 10.1016/j.ejrad.2011.07.013

C. Hordonneau, A. Buisson, J. Scanzi, F. Goutorbe, B. Pereira et al., Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity, The American Journal of Gastroenterology, vol.102, issue.1, pp.89-98
DOI : 10.1038/ajg.2013.385

J. Rimola, I. Ordás, S. Rodriguez, O. García-bosch, M. Aceituno et al., Magnetic resonance imaging for evaluation of Crohn??s disease, Inflammatory Bowel Diseases, vol.17, issue.8, pp.1759-68, 2011.
DOI : 10.1002/ibd.21551

I. Ordás, J. Rimola, S. Rodríguez, J. Paredes, M. Martínez-pérez et al., Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease, Gastroenterology, vol.146, issue.2, pp.374-382, 2014.
DOI : 10.1053/j.gastro.2013.10.055

M. Silverberg, J. Satsangi, T. Ahmad, I. Arnott, C. Bernstein et al., Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology, Montreal World Congress of Gastroenterology, pp.5-36, 2005.
DOI : 10.1155/2005/269076

Y. Bouhnik, Endoscopie des maladies inflammatoires chroniques intestinales, 2014.

A. Buisson, J. Filippi, A. Amiot, G. Cadiot, M. Allez et al., Su1229 Definitions of the Endoscopic Lesions in Crohn's Disease: Reproductibility Study and GETAID Expert Consensus, Gastroenterology, vol.148, issue.4, p.445, 2015.
DOI : 10.1016/S0016-5085(15)31500-6

Y. Bouhnik, Les scores endoscopiques en pratique courante [Internet]. symposium SFED 2014 Available from: http://services.y-congress.com/congress, p.7769, 2015.

R. Modigliani, Reproducibility of colonoscopic findings in Crohn's disease: a prospective multicenter study of interobserver variation, Dig Dis Sci, vol.32, issue.12, pp.1370-1379, 1987.

A. Dohan, S. Taylor, C. Hoeffel, M. Barret, M. Allez et al., Diffusion-weighted MRI in Crohn's disease: Current status and recommendations, Journal of Magnetic Resonance Imaging, vol.148, issue.Suppl 1, 2016.
DOI : 10.1002/jmri.25325

S. Punwani, M. Rodriguez-justo, A. Bainbridge, R. Greenhalgh, D. Vita et al., Mural Inflammation in Crohn Disease: Location-Matched Histologic Validation of MR Imaging Features, Radiology, vol.252, issue.3, pp.712-732, 2009.
DOI : 10.1148/radiol.2523082167

M. Zappa, C. Stefanescu, D. Cazals-hatem, F. Bretagnol, L. Deschamps et al., Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn??s disease? A retrospective comparison with surgical pathologic analysis, Inflammatory Bowel Diseases, vol.17, issue.4, pp.984-93, 2011.
DOI : 10.1002/ibd.21414

J. Makanyanga and S. Taylor, Current and Future Role of MR Enterography in the Management of Crohn Disease, American Journal of Roentgenology, vol.201, issue.1, pp.56-64
DOI : 10.2214/AJR.12.10406

J. Rimola, N. Planell, S. Rodríguez, S. Delgado, I. Ordás et al., Characterization of Inflammation and Fibrosis in Crohn???s Disease Lesions by Magnetic Resonance Imaging, The American Journal of Gastroenterology, vol.28, issue.3, pp.432-472
DOI : 10.1007/s10334-012-0355-2

C. Herrera-deguise, F. Casellas, V. Robles, E. Navarro, and N. Borruel, Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.22, issue.6, pp.1450-1455
DOI : 10.1097/MIB.0000000000000768

J. Matowicka-karna, Markery zapalenia, aktywacja p??ytek krwi i zaburzenia krzepni??cia w chorobach zapalnych jelit, Post??py Higieny i Medycyny Do??wiadczalnej, vol.70, pp.305-317, 2016.
DOI : 10.5604/17322693.1199305

URL : http://doi.org/10.5604/17322693.1199305

S. Vermeire, G. Van-assche, and P. Rutgeerts, C-Reactive Protein as a Marker for Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.10, issue.5, pp.661-666, 2004.
DOI : 10.1097/00054725-200409000-00026

Y. Wu, Y. He, F. Chen, T. Feng, M. Li et al., Nutritional risk screening in patients with Crohn's disease]. Zhonghua Yi Xue Za Zhi, Feb, vol.96, issue.6, pp.442-448, 2016.

C. Savoye-collet, J. Roset, E. Koning, C. Charpentier, S. Hommel et al., Magnetic resonance colonography in severe attacks of ulcerative colitis, European Radiology, vol.34, issue.9, pp.1963-71, 2012.
DOI : 10.1007/s00330-012-2456-8

A. Buisson, C. Hordonneau, M. Goutte, L. Boyer, B. Pereira et al., Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease, Alimentary Pharmacology & Therapeutics, vol.21, issue.4, pp.452-60, 2015.
DOI : 10.1111/apt.13287

J. Panés, R. Bouzas, M. Chaparro, V. García-sánchez, J. Gisbert et al., Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn???s disease, Alimentary Pharmacology & Therapeutics, vol.17, issue.2
DOI : 10.1111/j.1365-2036.2011.04710.x

A. Spinelli, G. Fiorino, P. Bazzi, M. Sacchi, C. Bonifacio et al., Preoperative Magnetic Resonance Enterography in Predicting Findings and Optimizing Surgical Approach in Crohn's Disease, Journal of Gastrointestinal Surgery, vol.243, issue.2, pp.83-90, 2014.
DOI : 10.1007/s11605-013-2404-1

A. Jauregui-amezaga, J. Rimola, I. Ordás, S. Rodríguez, A. Ramírez-morros et al., Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics, Gut, vol.17, issue.9, pp.1397-402, 2009.
DOI : 10.1136/gutjnl-2014-308101

E. Louis, J. Mary, G. Vernier-massouille, J. Grimaud, Y. Bouhnik et al., Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped, Gastroenterology, vol.142, issue.1, pp.63-70, 2012.
DOI : 10.1053/j.gastro.2011.09.034

M. Kwak, K. Kim, S. Park, D. Yang, B. Ye et al., Elevated C-reactive protein is associated with disease progression in patients with mild Crohn???s disease, SpringerPlus, vol.20, issue.5, p.878, 2016.
DOI : 10.1016/j.crohns.2013.08.009

D. Incà, R. , D. Pont, E. , D. Leo et al., Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?, The American Journal of Gastroenterology, vol.41, issue.8, pp.2007-2021, 2008.
DOI : 10.1111/j.1572-0241.2008.01870.x

A. Schoepfer, C. Beglinger, A. Straumann, M. Trummler, S. Vavricka et al., Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI, The American Journal of Gastroenterology, vol.77, issue.1, pp.162-171, 2009.
DOI : 10.1038/ajg.2009.545

E. Zittan, O. Kelly, R. Kirsch, R. Milgrom, J. Burns et al., Su1216 Low Fecal Calprotectin Correlates With Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease, Gastroenterology, vol.148, issue.4, pp.623-653, 2016.
DOI : 10.1016/S0016-5085(15)31487-6

T. Inokuchi, J. Kato, S. Hiraoka, S. Takashima, A. Nakarai et al., Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn??s Disease, Inflammatory Bowel Diseases, vol.22, issue.5, pp.1078-85, 2016.
DOI : 10.1097/MIB.0000000000000728

E. Louis, Epidemiology of the Transition from Early to Late Crohn??s Disease, Digestive Diseases, vol.30, issue.4, pp.376-385, 2012.
DOI : 10.1159/000338129

M. Henriksen, J. Jahnsen, I. Lygren, E. Aadland, T. Schulz et al., Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study), Scandinavian Journal of Gastroenterology, vol.4, issue.4, pp.602-612, 2007.
DOI : 10.1111/j.1572-0241.2002.05475.x

A. Caruso, R. D?incà, M. Scarpa, P. Manfrin, M. Rudatis et al., Diffusion-Weighted Magnetic Resonance for Assessing Ileal Crohn??s Disease Activity, Inflammatory Bowel Diseases, vol.20, issue.9, pp.1575-83, 2014.
DOI : 10.1097/MIB.0000000000000128

A. Buisson, A. Joubert, P. Montoriol, D. Ines, D. Ines et al., Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn
DOI : 10.1111/apt.12201

A. Buisson, C. Hordonneau, M. Goutte, J. Scanzi, F. Goutorbe et al., Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, pp.260-266, 2016.
DOI : 10.1016/j.dld.2015.10.019